Log in or Sign up for Free to view tailored content for your specialty!
Regulatory/Legislative News
InSite, Nicox enter licensing agreement for AzaSite, AzaSite Xtra and BromSite
InSite Vision and Nicox have entered into a licensing agreement for the development and commercialization of InSite’s AzaSite, AzaSite Xtra and BromSite, according to a press release.
FDA approves anti-allergy agent from Alcon
The U.S. Food and Drug Administration has granted U.S. marketing approval to Pazeo, a solution for ocular allergy itch relief from Alcon.
Log in or Sign up for Free to view tailored content for your specialty!
New CPT code published for corneal hysteresis
A new CPT code for measuring corneal hysteresis has been published, according to a press release issued by Reichert Technologies, which manufactures the Ocular Response Analyzer.
FDA approves two Tecnis multifocal IOLs from Abbott
The U.S. Food and Drug Administration approved Abbott’s +2.75 D and +3.25 D Tecnis one-piece multifocal IOLs, according to a press release.
Iluvien receives marketing authorization in Finland, Luxembourg
The Finnish Medicines Agency in Finland and the Ministry of Health in Luxembourg have granted Iluvien marketing authorization for the treatment of vision impairment associated with chronic diabetic macular edema, according to a press release from Alimera Sciences.
FDA clears creation of intracorneal pockets with iFS
The U.S. Food and Drug Administration has cleared the creation of intracorneal pockets using the iFS advanced femtosecond laser system, according to a press release from Abbott.
BLOG: 'Keeping an eye on your health'
In keeping with my new practice focus of primary health care, I present myself and gear my patient care to a more holistic attitude.
Ophthalmic industry growing despite static reimbursements
WAILEA, Hawaii – The “good news” in 2015 is that ophthalmology is a growth industry, according to Kevin J. Corcoran, COE, CPC, FNAO.
Physicians should screen employees against the OIG exclusion list
WAILEA, Hawaii — Physicians should frequently screen their employees against the Office of Inspector General exclusion list, according to a speaker here.
RetroSense Therapeutics secures $6 million in Series A financing
RetroSense Therapeutics has secured $6 million in Series A financing to investigate the use of gene therapy and optogenetics to restore vision loss, according to a press release.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read